Impact of depressive symptoms on motivation in persons with post-COVID-19 condition.
West J, Kwan A, Teopiz K, Guo Z, Le G, Badulescu S, Rhee T, Wong S, Cao B, Ho R, Rosenblat J, Mansur R, Phan L, Subramaniapillai M, McIntyre R. Impact of depressive symptoms on motivation in persons with post-COVID-19 condition. CNS Spectrums 2024, 1-5. PMID: 39655430, DOI: 10.1017/s1092852924000440.Peer-Reviewed Original ResearchDepressive symptomsMotivational deficitsPost hoc analysisQuick Inventory of Depressive Symptomatology-Self ReportInventory of Depressive Symptomatology-Self ReportQIDS-SR-16Impact of depressive symptomsDepressive symptom severityPost-COVID-19 conditionPost-hocMotivational impairmentsCognitive symptomsSymptom severityMotivational systemsMedical/psychiatric conditionsPlacebo-controlled trialCOVID-19 infectionWorld Health OrganizationSystem QuestionnaireDouble-blindAcute SARS-CoV-2 infectionOnset of symptomsHistory of COVID-19 infectionSymptomsPersonsGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®)
McIntyre R, Mansur R, Rosenblat J, Rhee T, Cao B, Teopiz K, Wong S, Le G, Ho R, Kwan A. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®). Journal Of Affective Disorders 2024, 369: 922-927. PMID: 39433133, DOI: 10.1016/j.jad.2024.10.062.Peer-Reviewed Original ResearchGLP-1 RAsReporting Odds RatioFood and Drug AdministrationFDA Adverse Event Reporting SystemGLP-1European Medicines AgencyMeasures of suicidalityWorld Health OrganizationGlucagon-like peptide-1 receptor agonistsGlucagon-like peptide 1 receptor agonistsWorld Health Organization pharmacovigilance databasePeptide-1 receptor agonistsPeptide 1 receptor agonistsUnited States Food and Drug AdministrationRA exposureStates Food and Drug AdministrationSuicidal behaviorSuicidal ideationAdverse Event Reporting SystemSuicideReceptor agonistsEvent Reporting SystemSemaglutideOdds ratioPharmacovigilance database